PTEN-loss confers dependence on the guanylate synthesis enzyme IMPDH in T-cell acute lymphoblastic leukemia
Rayees Ahmad Padder, Thu Le Le, Emily Hyde, Maria Rubio, Eric N. Chiles, Namratha Sheshadri, Kelly Mulraney, Wei Zong, Xiaoyang Su, Daniel Herranz, Alexander J. Valvezan
This paper identifies IMPDH as a therapeutic target in PTEN-deficient T-ALL, showing IMPDH inhibitors selectively kill these cells and extend survival in mouse models.
bioRxiv · Dec 24, 2025 · PreprintCancer Biology